5SFY

Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[(E)-2-[2-methyl-5-(1H-pyrazol-4-yl)-1,2,4-triazol-3-yl]ethenyl]-[1,2,4]triazolo[1,5-a]pyrazine

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SLS BEAMLINE X10SA
Synchrotron site	SLS
Beamline	X10SA
Temperature [K]	100
Detector technology	PIXEL
Collection date	2012-11-12
Detector	PSI PILATUS 6M
Wavelength(s)	0.999980
Spacegroup name	H 3
Unit cell lengths	135.137, 135.137, 234.830
Unit cell angles	90.00, 90.00, 120.00

Refinement procedure

Resolution	43.470 - 2.080
R-factor	0.1844
Rwork	0.182
R-free	0.22490
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	inhouse model
RMSD bond length	0.012
RMSD bond angle	1.504
Data reduction software	XDS
Data scaling software	XSCALE
Phasing software	PHASER
Refinement software	REFMAC (5.7.0029)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	43.470	43.470	2.130
High resolution limit [Å]	2.080	9.300	2.080
Rmerge	0.081	0.018	1.310
Rmeas	0.095	0.020	1.466
Total number of observations	500419
Number of reflections	95920	1077	7050
<I/σ(I)>	12.48	64.45	1.22
Completeness [%]	99.9	99.1	99.8
Redundancy	5.21	5.354	4.982
CC(1/2)	0.999	1.000	0.451

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7.5	295	5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2